JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.61% |
| 2 | Technology | 23.17% |
| 3 | Financials | 10.12% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
SLN
5951
Silence Therapeutics
SLN
$666M
| $26.1K | ﹤0.01% |
+3,793
| New | +$48.9K |
2024 Q4
0 quarters
|
|
|
AGEN
5952
Agenus
AGEN
$376M
| $26K | ﹤0.01% |
9,497
+369
| +4% | +$1.37K |
2017 Q3
29 quarters
|
|
5953
FT Vest International Equity Buffer ETF September
YSEP
$125M
| $26K | ﹤0.01% |
1,198
-15,916
| -93% | -$352K |
2024 Q1
3 quarters
|
|
5954
FibroBiologics
FBLG
$8.42M
| $26K | ﹤0.01% |
650
+38
| +6% | +$2.04K |
2024 Q1
3 quarters
|
|
5955
CALL
Shake Shack
SHAK
$2.43B
| $26K | ﹤0.01% |
200
| – | – |
2024 Q2
2 quarters
|
|
|
5956
PUT
Shake Shack
SHAK
$2.43B
| $26K | ﹤0.01% |
200
| – | – |
2024 Q2
2 quarters
|
|
5957
McCormick & Company Voting
MKC.V
$12.3B
| $25.8K | ﹤0.01% |
+341
| New | +$26.8K |
2024 Q4
0 quarters
|
|
5958
908 Devices
MASS
$517M
| $25.8K | ﹤0.01% |
11,747
+808
| +7% | +$2.31K |
2021 Q1
15 quarters
|
|
5959
Pacer Aristotle Pacific Floating Rate High Income ETF
FLRT
$790M
| $25.8K | ﹤0.01% |
+543
| New | +$25.9K |
2024 Q4
0 quarters
|
|
|
SGMO
5960
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $25.5K | ﹤0.01% |
25,000
+21,793
| +680% | +$39.8K |
2016 Q4
32 quarters
|
|
5961
Innovator US Small Cap Power Buffer ETF July
KJUL
$227M
| $25.1K | ﹤0.01% |
854
-2,849
| -77% | -$84.3K |
2024 Q1
3 quarters
|
|
5962
Team
TISI
$130M
| $25K | ﹤0.01% |
1,974
+1,957
| +11,512% | +$34.9K |
2013 Q2
46 quarters
|
|
5963
Gevo
GEVO
$324M
| $25K | ﹤0.01% |
11,942
-1,557
| -12% | -$2.95K |
2019 Q4
20 quarters
|
|
5964
First Trust Eurozone AlphaDEX
FEUZ
$113M
| $25K | ﹤0.01% |
616
-1,023
| -62% | -$42.7K |
2023 Q1
7 quarters
|
|
|
TYG
5965
Tortoise Energy Infrastructure Corp
TYG
$959M
| $24.9K | ﹤0.01% |
+593
| New | +$25K |
2024 Q4
0 quarters
|
|
5966
Amplify Alternative Harvest ETF
MJ
$104M
| $24.9K | ﹤0.01% |
925
-798
| -46% | -$26.7K |
2022 Q4
8 quarters
|
|
|
MTA
5967
Metalla Royalty & Streaming
MTA
$867M
| $24.8K | ﹤0.01% |
9,900
| – | – |
2024 Q3
1 quarter
|
|
5968
Greystone Housing Impact Investors LP
GHI
$130M
| $24.8K | ﹤0.01% |
2,424
-457
| -16% | -$5.49K |
2022 Q2
10 quarters
|
|
5969
GS ActiveBeta US Small Cap Equity ETF
GSSC
$1.04B
| $24.8K | ﹤0.01% |
359
+8
| +2% | +$572 |
2023 Q1
7 quarters
|
|
|
P
5970
CALL
Everpure Inc
P
$44.7B
| $24.6K | ﹤0.01% |
400
-7,700
| -95% | -$429K |
2024 Q2
2 quarters
|
|
5971
vTv Therapeutics
VTVT
$126M
| $24.6K | ﹤0.01% |
+1,803
| New | +$26.7K |
2024 Q4
0 quarters
|
|
|
LRFC
5972
DELISTED
Logan Ridge Finance Corp
LRFC
| $24.5K | ﹤0.01% |
1,000
| – | – |
2023 Q2
6 quarters
|
|
|
ARTY
5973
iShares Future AI & Tech ETF
ARTY
$4.27B
| $24.4K | ﹤0.01% |
657
-1,334
| -67% | -$48.5K |
2023 Q4
4 quarters
|
|
5974
New Horizon Aircraft Ltd
HOVRW
$9.99M
| – | – |
0
| – | – |
2023 Q4
4 quarters
|
|
5975
Gabelli Equity Trust
GAB
$1.79B
| $24.2K | ﹤0.01% |
4,500
-300
| -6% | -$1.66K |
2015 Q4
36 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 509 new, 3,351 increased, 2,465 reduced and 522 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 509 new positions and closed 522 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.